Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs)

Journal of Molecular Histology

Volumn 42, Issue 4, 2011, Pages 323-331

  De Barros, Érica Peres ^a,b   Garcia Pinto, Angélica Beatriz ^a,b   MacHado, Priscilla Yório ^a   Dos Santos Pereira, Mário José ^a   De Carvalho, Jorge José ^a  

^a Inst Biol Roberto Alcantara Gomes   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Connexin 43; Hypertension; Kidney; Rosuvastatin; SHR; Ultrastructure

Indexed keywords

CONNEXIN 43; CREATINE KINASE; CREATININE; ROSUVASTATIN; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG EFFECT; GLOMERULAR STRUCTURE; IMMUNOFLUORESCENCE; KIDNEY STRUCTURE; MORPHOMETRICS; NONHUMAN; PLEIOTROPY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSMISSION ELECTRON MICROSCOPY; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; FLUOROBENZENES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; KIDNEY GLOMERULUS; PROTEINURIA; PYRIMIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SULFONAMIDES;

ANIMALIA; RATTUS;

EID: 80052572371     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-011-9336-4     Document Type: Article

References (30)

1. Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de Crespigny PJ, DeFerrari G, Drury P, Locatelli F, Wiegmann TB, Lewis EJ (2005) Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 45:281-287 (Pubitemid 40431053)
2. Bae EH, Kim IJ, Park JW, Ma SK, Lee JU, Kim SW (2009) Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats. Nephrol Dial Transpl 25:1051-1059
3. Barri YM (2008) Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 10:39-45 (Pubitemid 351255952)
4. Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R (2009) Protective importance of the myogenic response in the renal circulation. Hypertension 54:393-398
5. Chen SH, Chou FF, Ko JY (2010) The use of simvastatin with aromasin in an ovariectomized rat model: effects on the skeletal system. Chang Gung Med J 33:509-514
6. Ciani L, Patel A, Allen ND, Ffrench-Constant C (2003) Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 23:3575-3582 (Pubitemid 36539190)
7. Cormack-Aboud FC, Brinkkoetter PT, Pippin JW, Shankland SJ, Durvasula RV (2009) Rosuvastatin protects against podocyte apoptosis in vitro. Nephrol Dial Transpl 24:404-412
8. Dlugosova K, Okruhlicova L, Mitasikova M, Sotnikova R, Bernatova I, Weismann P, Slezak J, Tribulova N (2009) Modulation of connexin-43 by omega-3 fatty acids in the aorta of old spontaneously hypertensive rats. J Physiol Pharmacol 60:63-69
9. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, Barrish JP, Mathur BN, Turner CA, Geske R, Montgomery CA, Starbuck M, Brandt M, Gupta A, Ramirez-Solis R, Zambrowicz BP, Powell DR (2001) Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 21:4829-4836 (Pubitemid 32588261)
10. Flack JM, Ferdinand KC, Nasser SA, Rossi NF (2010) Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populations. Cardiol Clin 28:623-638
11. Gianella A, Nobili E, Abbate M, Zoja C, Gelosa P, Mussoni L, Bellosta S, Canavesi M, Rottoli D, Guerrini U, Brioschi M, Banfi C, Tremoli E, Remuzzi G, Sironi L (2007) Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. Am J Pathol 170:1165-1177 (Pubitemid 47339325)
12. Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J (2010) Connexins and the kidney. Am J Physiol Regul Integr Comp Physiol 298:R1143-R1155
13. Hedenmalm K, Alvan G, Ohagen P, Dahl ML (2010) Muscle toxicity with statins. Pharmacoepidemiol Drug Saf 19:223-231
14. Krzesinski JM, Cohen EP (2007) Hypertension and the kidney. Acta Clin Belg 62:5-14 (Pubitemid 46521983)
15. Loch D, Levick S, Hoey A, Brown L (2006) Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol 47:396-404 (Pubitemid 44309693)
16. Neto-Ferreira R, Novaes Rocha V, da Silva Torres T, Mandarim-de-Lacerda CA, de Carvalho JJ (2011). Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxidedeficient rats. Exp Toxicol Pathol 63(5):473-478
17. Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE (2007) Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297:499-508 (Pubitemid 46220805)
18. Ofstad J, Iversen BM (2005) Glomerular and tubular damage in normotensive and hypertensive rats. Am J Physiol Renal Physiol 288:F665-F672 (Pubitemid 40381733)
19. Ossani GP, Castiglia NI, Martino MF, Fariña SL, Uceda AM, Monsserrat AJ (2009) Morphometry of the glomerular tuft during normal postnatal growth in female rats. Effects of age, location of glomeruli and methods of obtaining and processing the renal tissue. Scand J Lab Anim Sci 36:265-269
20. Palmer BF, Fenves AZ (2010) Optimizing blood pressure control in patients with chronic kidney disease. Proc Bayl Univ Med Cent 23:239-245
21. Pfefferkorn JA (2011) Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review. Expert Opin Ther Pat 21:187-203
22. Putaala H, Soininen R, Kilpeläinen P, Wartiovaara J, Tryggvason K (2001) The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10:1-8 (Pubitemid 32051561)
23. Ren Y, D'Ambrosio MA, Liu R, Pagano PJ, Garvin JL, Carretero AO (2010) Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 298:H1769-H1775
24. Renke M, Tylicki L, Rutkowski P, Neuwelt A, Larczyński W, Ziȩtkiewicz M, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B (2010) Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Acta Biochim Pol 57:547-552
25. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C (2004) Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 24:550-560 (Pubitemid 38057908)
26. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC (2008) Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomized controlled trials. Bmj 336:645-651 (Pubitemid 351481234)
27. Suh JW, Choi DJ, Chang HJ, Cho YS, Youn TJ, Chae IH, Kim KI, Kim CH, Kim HS, Oh BH, Park YB (2010) HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase. J Korean Med Sci 25:16-23
28. Tryggvason K, Patrakka J, Wartiovaara J (2006) Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354:1387-1401
29. Verhulst A, Sayer R, De Broe ME, D'Haese PC, Brown CD (2008) Human proximal tubular epithelium actively secretes but does not retain rosuvastatin. Mol Pharmacol 74:1084-1091
30. Yaoita E, Yao J, Yoshida Y, Morioka T, Nameta M, Takata T, Kamiie J, Fujinaka H, Oite T, Yamamoto T (2002) Up-Regulation of Connexin43 in Glomerular Podocytes in response to Injury. Am J Path 161:1597-1606 (Pubitemid 35265520)